Lanean...
Synergistic antitumor efficacy by combining adriamycin with recombinant human endostatin in an osteosarcoma model
In the last 15 years, chemotherapy-based therapeutic regimens for the treatment of osteosarcoma have failed to demonstrate improved survival rates. Novel approaches, including targeted therapy and antiangiogenic therapy, may provide new methods for the treatment of osteosarcoma, one of the most dead...
Gorde:
Egile Nagusiak: | , , , , , , |
---|---|
Formatua: | Artigo |
Hizkuntza: | Inglês |
Argitaratua: |
D.A. Spandidos
2011
|
Gaiak: | |
Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3408098/ https://ncbi.nlm.nih.gov/pubmed/22866125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.334 |
Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|